Results of the use of ramucirumab in combination with irinotecan and fluoropyrimidines in the second-line chemotherapy for disseminated gastric cancer

Results of the use of ramucirumab in combination with irinotecan and fluoropyrimidines in the second-line chemotherapy for disseminated gastric cancer

Background: Several studies show that the combination chemotherapy with ramucirumab allows to improve the treatment results of advanced gastric cancer (GC). Irinotecan with fluoropyrimidines is own of the second line chemotherapy options for these patients. As angiogenesis inhibitors can enhance the...

Full description

Bibliographic Details
Main Authors: N. S. Besova, T. A. Titova, D. L. Stroyakovsky, E. V. Perminova, S. G. Bagrova, E. S. Obarevich, V. A. Gorbunova, E. V. Artamonova, I. S. Stilidi
Format: Article
Language:Russian
Published: Remedium Group LLC 2019-06-01
Series:Медицинский совет
Subjects:
ramucirumab
gastric cancer
irinotecan
fluoropyrimidine adenocarcinoma
second line treatment
Online Access:https://www.med-sovet.pro/jour/article/view/3059

Similar Items

Similar Items